CYTOKINETICS INC's ticker is and the CUSIP is 23282W905. A total of 2 filers reported holding CYTOKINETICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $15,972,264 | -47.9% | 294,800 | -32.6% | 0.06% | -47.5% |
Q1 2024 | $30,645,081 | -69.1% | 437,100 | -63.2% | 0.12% | -54.8% |
Q4 2023 | $99,119,328 | +4855.1% | 1,187,200 | +1648.5% | 0.26% | +3628.6% |
Q3 2023 | $2,000,334 | +148.3% | 67,900 | +174.9% | 0.01% | +133.3% |
Q2 2023 | $805,714 | -47.4% | 24,700 | -43.2% | 0.00% | -50.0% |
Q1 2023 | $1,530,765 | -33.0% | 43,500 | -12.8% | 0.01% | +20.0% |
Q4 2022 | $2,286,418 | +84.4% | 49,900 | +94.9% | 0.01% | +150.0% |
Q3 2022 | $1,240,000 | -17.6% | 25,600 | -33.2% | 0.00% | 0.0% |
Q2 2022 | $1,505,000 | +146.3% | 38,300 | +130.7% | 0.00% | +100.0% |
Q1 2022 | $611,000 | -57.6% | 16,600 | -47.5% | 0.00% | 0.0% |
Q4 2021 | $1,440,000 | +34.7% | 31,600 | +5.7% | 0.00% | 0.0% |
Q3 2021 | $1,069,000 | +6581.2% | 29,900 | +3637.5% | 0.00% | – |
Q2 2021 | $16,000 | -97.8% | 800 | -97.5% | 0.00% | -100.0% |
Q1 2021 | $730,000 | -53.0% | 31,400 | -58.0% | 0.00% | -66.7% |
Q4 2020 | $1,554,000 | -29.2% | 74,800 | -26.2% | 0.00% | -57.1% |
Q3 2020 | $2,195,000 | +89.2% | 101,400 | +106.1% | 0.01% | +40.0% |
Q2 2020 | $1,160,000 | -56.7% | 49,200 | -78.3% | 0.01% | -77.3% |
Q1 2020 | $2,676,000 | +221.2% | 227,000 | +189.2% | 0.02% | +266.7% |
Q4 2019 | $833,000 | +390.0% | 78,500 | +426.8% | 0.01% | +500.0% |
Q3 2019 | $170,000 | -16.3% | 14,900 | -17.2% | 0.00% | -50.0% |
Q2 2019 | $203,000 | +79.6% | 18,000 | +28.6% | 0.00% | +100.0% |
Q1 2019 | $113,000 | +10.8% | 14,000 | -13.6% | 0.00% | 0.0% |
Q4 2018 | $102,000 | -49.0% | 16,200 | -20.2% | 0.00% | -50.0% |
Q3 2018 | $200,000 | +640.7% | 20,300 | +515.2% | 0.00% | – |
Q2 2018 | $27,000 | -88.1% | 3,300 | -89.5% | 0.00% | -100.0% |
Q1 2018 | $227,000 | -40.3% | 31,500 | -32.4% | 0.00% | -33.3% |
Q4 2017 | $380,000 | +109.9% | 46,600 | +272.8% | 0.00% | +50.0% |
Q3 2017 | $181,000 | -40.8% | 12,500 | -50.6% | 0.00% | -33.3% |
Q2 2017 | $306,000 | -46.2% | 25,300 | -42.9% | 0.00% | -57.1% |
Q1 2017 | $569,000 | +244.8% | 44,300 | +225.7% | 0.01% | +250.0% |
Q4 2016 | $165,000 | -89.5% | 13,600 | -92.1% | 0.00% | -88.2% |
Q3 2016 | $1,575,000 | +328.0% | 171,600 | +342.3% | 0.02% | +325.0% |
Q2 2016 | $368,000 | -1.1% | 38,800 | -26.4% | 0.00% | -20.0% |
Q1 2016 | $372,000 | +30.5% | 52,700 | +93.8% | 0.01% | +66.7% |
Q4 2015 | $285,000 | +64.7% | 27,200 | +5.0% | 0.00% | +50.0% |
Q3 2015 | $173,000 | -54.4% | 25,900 | -54.1% | 0.00% | -60.0% |
Q2 2015 | $379,000 | -5.7% | 56,400 | -4.9% | 0.01% | -16.7% |
Q1 2015 | $402,000 | -3.4% | 59,300 | +14.3% | 0.01% | 0.0% |
Q4 2014 | $416,000 | +235.5% | 51,900 | +47.9% | 0.01% | +200.0% |
Q3 2014 | $124,000 | -72.4% | 35,100 | -62.6% | 0.00% | -71.4% |
Q2 2014 | $449,000 | +28.3% | 93,900 | +155.2% | 0.01% | +16.7% |
Q1 2014 | $350,000 | +348.7% | 36,800 | +206.7% | 0.01% | +500.0% |
Q4 2013 | $78,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 361,500 | $3,434,000 | 1.59% |
SABBY MANAGEMENT, LLC | 661 | $628,000 | 0.04% |
GROUP ONE TRADING, L.P. | 36,800 | $350,000 | 0.01% |
SPHERA FUNDS MANAGEMENT LTD. | 131 | $16,000 | 0.00% |
Citadel Advisors | 5,900 | $56,000 | 0.00% |